Company profile ALXO

Alx Oncology Holdings Inc
alx oncology (previously alexo therapeutics) is a clinical-stage immuno-oncology company developing therapies that block the cd47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system. our lead candidate, alx148, is a fusion protein that comprises an engineered high affinity cd47 binding domain of sirpa linked to an inactive fc region of human immuno...globulin. alx148 is currently being investigated in a phase 1 study in combination with checkpoint inhibitors and targeted anti-cancer antibodies (nct03013218). for more information about the company, please visit our website at www.alxoncology.com Show More
Quarter analysis & expected interestLast update: February 08 2024 14:31:31.

After 39 days of this quarter the interest is at 117.0. Based on that we can calculate that during remaining 52 days it will total up to 273.0.
ALX Oncology Holdings expected interest is significantly higher compared to previous quarter (+446.0%) and same quarter last year (+582.5%).

YearQ1Q2Q3Q4
201910
11
10.0% QoQ
56
409.1% QoQ
15
-73.2% QoQ
2020 47
370.0% YoY 213.3% QoQ
32
190.9% YoY -31.9% QoQ
16
-71.4% YoY -50.0% QoQ
45
200.0% YoY 181.2% QoQ
2021 42
-10.6% YoY -6.7% QoQ
58
81.2% YoY 38.1% QoQ
124
675.0% YoY 113.8% QoQ
41
-8.9% YoY -66.9% QoQ
2022 41
-2.4% YoY 0.0% QoQ
55
-5.2% YoY 34.1% QoQ
41
-66.9% YoY -25.5% QoQ
17
-58.5% YoY -58.5% QoQ
2023 40
-2.4% YoY 135.3% QoQ
22
-60.0% YoY -45.0% QoQ
23
-43.9% YoY 4.5% QoQ
50
194.1% YoY 117.4% QoQ
2024 117
192.5% YoY 134.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ALX Oncology Holdings search interestLast update: February 08 2024 14:31:30.
Correlation coefficient between keyword and revenue is -0.13
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:31:32.

The average 5 years interest of ALX Oncology Holdings was 3.46 per week.
The last year interest of ALX Oncology Holdings compared to the last 5 years has changed by 17.92%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 130.51%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:31:36.

After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0.
evorpacept expected interest is significantly higher compared to previous quarter (+124.0%) and same quarter last year (+223.6%).

YearQ1Q2Q3Q4
201927
24
-11.1% QoQ
29
20.8% QoQ
17
-41.4% QoQ
2020 44
63.0% YoY 158.8% QoQ
12
-50.0% YoY -72.7% QoQ
102
251.7% YoY 750.0% QoQ
49
188.2% YoY -52.0% QoQ
2021 13
-70.5% YoY -73.5% QoQ
72
500.0% YoY 453.8% QoQ
62
-39.2% YoY -13.9% QoQ
49
0.0% YoY -21.0% QoQ
2022 23
76.9% YoY -53.1% QoQ
38
-47.2% YoY 65.2% QoQ
43
-30.6% YoY 13.2% QoQ
26
-46.9% YoY -39.5% QoQ
2023 72
213.0% YoY 176.9% QoQ
47
23.7% YoY -34.7% QoQ
21
-51.2% YoY -55.3% QoQ
104
300.0% YoY 395.2% QoQ
2024 100
38.9% YoY -3.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and evorpacept search interestLast update: February 08 2024 14:31:36.
Correlation coefficient between keyword and revenue is -0.68
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:31:37.

The average 5 years interest of evorpacept was 3.73 per week.
The last year interest of evorpacept compared to the last 5 years has changed by 62.47%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 174.21%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:31:44.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
ALXO stock price expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201957
83
45.6% QoQ
128
54.2% QoQ
153
19.5% QoQ
2020 45
-21.1% YoY -70.6% QoQ
121
45.8% YoY 168.9% QoQ
65
-49.2% YoY -46.3% QoQ
213
39.2% YoY 227.7% QoQ
2021 60
33.3% YoY -71.8% QoQ
76
-37.2% YoY 26.7% QoQ
64
-1.5% YoY -15.8% QoQ
87
-59.2% YoY 35.9% QoQ
2022 25
-58.3% YoY -71.3% QoQ
90
18.4% YoY 260.0% QoQ
17
-73.4% YoY -81.1% QoQ
43
-50.6% YoY 152.9% QoQ
2023 164
556.0% YoY 281.4% QoQ
109
21.1% YoY -33.5% QoQ
168
888.2% YoY 54.1% QoQ
153
255.8% YoY -8.9% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ALXO stock price search interestLast update: February 08 2024 14:31:44.
Correlation coefficient between keyword and revenue is 0.08
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:31:44.

The average 5 years interest of ALXO stock price was 7.36 per week.
The last year interest of ALXO stock price compared to the last 5 years has changed by 37.5%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 12.95%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:31:48.

After 39 days of this quarter the interest is at 219.0. Based on that we can calculate that during remaining 52 days it will total up to 511.0.
cancer treatment options expected interest is significantly lower compared to previous quarter (-42.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019493
705
43.0% QoQ
655
-7.1% QoQ
794
21.2% QoQ
2020 893
81.1% YoY 12.5% QoQ
584
-17.2% YoY -34.6% QoQ
783
19.5% YoY 34.1% QoQ
814
2.5% YoY 4.0% QoQ
2021 660
-26.1% YoY -18.9% QoQ
673
15.2% YoY 2.0% QoQ
724
-7.5% YoY 7.6% QoQ
807
-0.9% YoY 11.5% QoQ
2022 671
1.7% YoY -16.9% QoQ
668
-0.7% YoY -0.4% QoQ
611
-15.6% YoY -8.5% QoQ
707
-12.4% YoY 15.7% QoQ
2023 790
17.7% YoY 11.7% QoQ
726
8.7% YoY -8.1% QoQ
619
1.3% YoY -14.7% QoQ
883
24.9% YoY 42.6% QoQ
2024 219
-72.3% YoY -75.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and cancer treatment options search interestLast update: February 08 2024 14:31:47.
Correlation coefficient between keyword and revenue is -0.6
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:31:48.

The average 5 years interest of cancer treatment options was 55.48 per week.
The last year interest of cancer treatment options compared to the last 5 years has changed by -0.38%.
The interest for cancer treatment options is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -5.25%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for immuno-oncology therapies to provide analysis

Correlation between past revenue and immuno-oncology therapies search interest

There is not enough data for immuno-oncology therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for immuno-oncology therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CD47 blocking therapy to provide analysis

Correlation between past revenue and CD47 blocking therapy search interest

There is not enough data for CD47 blocking therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CD47 blocking therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ALX Oncology Holdings clinical trials to provide analysis

Correlation between past revenue and ALX Oncology Holdings clinical trials search interest

There is not enough data for ALX Oncology Holdings clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ALX Oncology Holdings clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ALX Oncology Holdings news to provide analysis

Correlation between past revenue and ALX Oncology Holdings news search interest

There is not enough data for ALX Oncology Holdings news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ALX Oncology Holdings news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ALX Oncology Holdings careers to provide analysis

Correlation between past revenue and ALX Oncology Holdings careers search interest

There is not enough data for ALX Oncology Holdings careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ALX Oncology Holdings careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:31:54.

After 39 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 52 days it will total up to 56.0.
ALXO -stock -company expected interest is significantly lower compared to previous quarter (-84.5%) and same quarter last year (-42.3%).

YearQ1Q2Q3Q4
2019115
15
-87.0% QoQ
39
160.0% QoQ
133
241.0% QoQ
2020 51
-55.7% YoY -61.7% QoQ
102
580.0% YoY 100.0% QoQ
170
335.9% YoY 66.7% QoQ
118
-11.3% YoY -30.6% QoQ
2021 213
317.6% YoY 80.5% QoQ
110
7.8% YoY -48.4% QoQ
69
-59.4% YoY -37.3% QoQ
127
7.6% YoY 84.1% QoQ
2022 113
-46.9% YoY -11.0% QoQ
87
-20.9% YoY -23.0% QoQ
185
168.1% YoY 112.6% QoQ
143
12.6% YoY -22.7% QoQ
2023 97
-14.2% YoY -32.2% QoQ
107
23.0% YoY 10.3% QoQ
190
2.7% YoY 77.6% QoQ
361
152.4% YoY 90.0% QoQ
2024 24
-75.3% YoY -93.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ALXO -stock -company search interestLast update: February 08 2024 14:31:53.
Correlation coefficient between keyword and revenue is -0.23
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:31:55.

The average 5 years interest of ALXO -stock -company was 9.84 per week.
The last year interest of ALXO -stock -company compared to the last 5 years has changed by 42.07%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 140.62%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ALXO
Earnings date: 2024-03-07 After close
Company name: Alx Oncology Holdings Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-08T12:00:00Z

GlobeNewswire
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

2026-05-07T12:00:00Z

GlobeNewswire
ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

2026-04-30T12:00:00Z

GlobeNewswire
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

2026-04-17T20:05:00Z

GlobeNewswire
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

2026-04-13T12:30:00Z

GlobeNewswire
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

2026-03-19T13:02:20Z

Analyst Upgrades
Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

2026-03-10T11:38:02Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

2026-02-27T13:00:00Z

GlobeNewswire
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

2026-02-19T13:33:00Z

GlobeNewswire
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026

2026-02-19T13:30:00Z

GlobeNewswire
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

2026-02-05T15:46:50Z

Analyst Upgrades
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $4

2026-01-30T13:30:21Z

GlobeNewswire
ALX Oncology Announces Pricing of Underwritten Offering

2026-01-30T13:15:00Z

GlobeNewswire
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer

2026-01-08T16:00:00Z

GlobeNewswire
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

2026-01-08T13:30:00Z

GlobeNewswire
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004